Over the course of more than 25 years as a patent attorney matched with in-house experience as a pharmaceutical chemist at DuPont Merck Pharmaceuticals and Smithkline Beecham, Allen Baum, partner-in-charge of the Raleigh office, has the ability to take complex scientific and legal issues and distill them into timely, relevant and useful counsel.
Allen R. Baum
He/Him
Partner
Raleigh
4208 Six Forks RoadSuite 1010
Raleigh, NC 27609-5738
Washington, D.C.
1717 Pennsylvania Avenue N.W.Suite 500
Washington, D.C. 20006-4623
Allen R. Baum
He/Him
Partner
Raleigh
4208 Six Forks RoadSuite 1010
Raleigh, NC 27609-5738
Washington, D.C.
1717 Pennsylvania Avenue N.W.Suite 500
Washington, D.C. 20006-4623
Over the course of more than 25 years as a patent attorney matched with in-house experience as a pharmaceutical chemist at DuPont Merck Pharmaceuticals and Smithkline Beecham, Allen Baum, partner-in-charge of the Raleigh office, has the ability to take complex scientific and legal issues and distill them into timely, relevant and useful counsel.
- OVERVIEW
- EXPERIENCE
- Presentations
- INSIGHTS AND EVENTS
Allen represents life sciences companies in patent and licensing matters. Clients hire Allen to identify and execute strategies to protect key commercial products, license important intellectual assets, and bring lucrative products to market in areas heavily patented by competitors. With an extensive litigation background, he is also frequently retained to evaluate the strength of patents under consideration for licensing, acquisition or investment.
Allen frequently assists clients with strategies for pursuing commercially significant patent portfolios and has managed large portfolios of patent applications for Global Fortune 100 companies. He has also provided opinions on patents protecting products with sales in excess of $1 billion. His representative clients are active in small molecule pharmaceuticals, agricultural products, biotechnology, biochemistry, vaccines, medical devices, ocular medications and implants, green technologies, and advanced materials.
Allen’s work includes post grant litigation and inter partes review before the U.S. Patent and Trademark Office, freedom-to-operate studies, due diligence review, infringement and validity studies, licensing, Hatch-Waxman litigation, reexamination, and patent preparation and prosecution.
Active in leadership roles in the IP industry, Allen is a former president of the Licensing Executives Society for the USA and Canada, a former president of the Board of Governor’s for Certified Licensing Professionals (CLP), and was managing partner of his prior firm’s Research Triangle Park office and served on its board of directors for four years. He is also a frequent instructor for intellectual asset management courses and a frequent speaker on life sciences IP topics.
Allen is not regularly admitted to practice in the local courts of Utah.
Allen is not regularly admitted to practice law in the local courts of the District of Columbia. Pursuant to Rule 49 his practice in the District of Columbia is limited to federal courts and agencies.
Professional and Community Involvement
Instructor, Licensing Executives Society on the Fundamentals and Intermediate Intellectual Asset Management Series
Former president, Licensing Executives Society for USA and Canada
Former president and board of governors chair, Certified Licensing Professionals (CLP)
Member, American Bar Association
Member, American Intellectual Property Law Association
Member, Licensing Executives Society
Member, Triangle Intellectual Property Law Association
Honors
LMG Life Sciences Life Science Star, 2018, 2022
Managing Intellectual Property, IP Star, 2013-2018; Patent Star - North Carolina, 2021
The Best Lawyers in America, 2005-2020, 2022-2023; Lawyer of the Year, 2018
Legal 500, Recommended Lawyer, 2017
Intellectual Asset Management, IAM Patent 1000: The World’s Leading Patent Practitioners, 2012-2018, 2020, 2022
Intellectual Asset Management, IAM 300: A Guide to the World's Leading IP Strategists, 2014
Intellectual Asset Management, IAM 250: The World’s Leading Patent & Technology Licensing Lawyers, 2010-2012
Intellectual Asset Management, IAM 250: A Guide to the World's Leading IP Strategists, 2009-2011
- Freedom to Operate: Evaluating Current Strategies to Avoid Future Findings of Infringement, 17th Life Sciences Patents Summit, New York City, May 16, 2019
- "Learning the Sweet Science: Win the New Boxing Match Known as Inter Partes Review," ACI's Comprehensive Guide to Patent Reform, New York City, Jan. 24, 2013
- "Assessing the Impact of New PTO Procedures Under the AIA on Hatch-Waxman Strategies Relative to Patent Life Cycle Management," ACI's Maximizing Pharmaceutical Patent Life Cycles, New York City, Oct. 9, 2012
- "Taking Action to Address Potential Roadblocks with Effective FTO Analysis" ACI’s 6th National Tactical and Practical Guide to Freedom to Operate, Philadelphia, Penn, July 31, 2012
- "Business Implications of Patent Reform: Taking the America Invents Act Into Account in Doing Deals," Licensing Executives Society's Research Triangle Park Chapter Meeting, Durham, NC, Feb. 14, 2012
- "Patent 101: Overview of the Fundamental Provisions in the America Invents Act" and "The Timeline of Enactment: Identifying What Needs to be Done Now and Planning for Future Changes," ACI 's Comprehensive Guide to Patent Reform for Life Science Companies, New York City, Jan. 30-31, 2012
- "Exclusivities and Forfeitures: New Developments, Controversies and Concerns," ACI's 12th Annual Maximizing Pharmaceutical Patent Life Cycles, New York City, Oct. 5, 2011
- "IP Law Essentials & Best Practices for Venture Capitalists: Everything You Need to Know About Protecting Intellectual Property in 60 Minutes," ExecSense Webinar, April 2011
- "Preparing for the Exit: Drafting Critical Termination Provisions," ACI's 14th Advanced Forum on Structuring, Negotiating and Managing Life Sciences Collaborative Agreements and Acquisitions, New York, NY, Feb. 17, 2011
- "The Role of the Regulatory Professional in the Due Diligence Process," 2010 RAPS Annual Conference & Exhibition, San Jose, CA, Oct. 25, 2010
- "Who is on the Hook? Indemnities in Patent Sale and Licenses," Intellectual Property Owners Association Webinar, Sept. 23, 2010